Literature DB >> 27395013

Functional imaging in liver tumours.

Maxime Ronot1, Ashley Kieran Clift2, Valérie Vilgrain3, Andrea Frilling2.   

Abstract

Functional imaging encompasses techniques capable of assessing physiological parameters of tissues, and offers useful clinical information in addition to that obtained from morphological imaging. Such techniques may include magnetic resonance imaging with diffusion-weighted sequences or hepatobiliary contrast agents, perfusion imaging, or molecular imaging with radiolabelled tracers. The liver is of major importance in oncological practice; not only is hepatocellular carcinoma one of the malignancies with steadily rising incidence worldwide, but hepatic metastases are regularly observed with a range of solid neoplasms. Within the realm of hepatic oncology, different functional imaging modalities may occupy pivotal roles in lesion characterisation, treatment selection and follow-up, depending on tumour size and type. In this review, we characterise the major forms of functional imaging, discuss their current application to the management of patients with common primary and secondary liver tumours, and anticipate future developments within this field.
Copyright © 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Imaging; Liver; Metastases; Tumours

Mesh:

Substances:

Year:  2016        PMID: 27395013     DOI: 10.1016/j.jhep.2016.06.024

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  22 in total

1.  The impact of injector-based contrast agent administration in time-resolved MRA.

Authors:  Johannes Budjan; Ulrike I Attenberger; Stefan O Schoenberg; Hubertus Pietsch; Gregor Jost
Journal:  Eur Radiol       Date:  2017-12-07       Impact factor: 5.315

2.  Laparoscopic Surgery for a Patient With Multiple Liver Metastases of Unknown Origin Concomitant With Gallbladder Tumor.

Authors:  Yoshihiro Hara; Kensuke Yamamura; Kazuki Matsumura; Eri Oda; Shinichi Akahoshi; Hideaki Yuki; Jun Tomiguchi; Toshihiko Motohara; Hideaki Miyamoto; Yoshihiko Komohara; Toru Beppu
Journal:  In Vivo       Date:  2021 Sep-Oct       Impact factor: 2.406

Review 3.  Transarterial Radioembolization Agents: a Review of the Radionuclide Agents and the Carriers.

Authors:  Aysheh Alrfooh; Aditi Patel; Sandeep Laroia
Journal:  Nucl Med Mol Imaging       Date:  2021-07-13

4.  Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in Mice.

Authors:  Yun Zhang; Jing Zhao; Jing Cai; Jia-Cong Ye; Yi-Tai Xiao; Yan Mei; Mu-Sheng Zeng; Chuan-Miao Xie; Yong Jiang; Guo-Kai Feng
Journal:  Mol Imaging Biol       Date:  2020-08       Impact factor: 3.488

5.  Comparison of the [18F]-FDG and [18F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular Carcinoma.

Authors:  David Brasse; Hélène Burckel; Patrice Marchand; Marc Rousseau; Ali Ouadi; Marie Vanstalle; Christian Finck; Patrice Laquerriere; Frédéric Boisson
Journal:  Mol Imaging Biol       Date:  2021-04-13       Impact factor: 3.488

Review 6.  Quantitative magnetic resonance imaging for focal liver lesions: bridging the gap between research and clinical practice.

Authors:  Roberto Cannella; Riccardo Sartoris; Jules Grégory; Lorenzo Garzelli; Valérie Vilgrain; Maxime Ronot; Marco Dioguardi Burgio
Journal:  Br J Radiol       Date:  2021-05-14       Impact factor: 3.629

7.  PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68 Ga-PSMA-11 PET Using Cyclotron-Produced 68 Ga.

Authors:  Scott M Thompson; Garima Suman; Michael S Torbenson; Zong-Ming E Chen; Danielle E Jondal; Anurima Patra; Eric C Ehman; James C Andrews; Chad J Fleming; Brian T Welch; Anil N Kurup; Lewis R Roberts; Kymberly D Watt; Mark J Truty; Sean P Cleary; Rory L Smoot; Julie K Heimbach; Nguyen H Tran; Amit Mahipal; Jun Yin; Tyler Zemla; Chen Wang; Zachary Fogarty; Mark Jacobson; Bradley J Kemp; Sudhakar K Venkatesh; Geoffrey B Johnson; David A Woodrum; Ajit H Goenka
Journal:  Hepatol Commun       Date:  2021-11-15

8.  Heptamethine carbocyanine DZ-1 dye for near-infrared fluorescence imaging of hepatocellular carcinoma.

Authors:  Jiaze An; Ningning Zhao; Caiqin Zhang; Yong Zhao; Dengxu Tan; Ya Zhao; Bing Bai; Hai Zhang; Boyang Jason Wu; Changhong Shi
Journal:  Oncotarget       Date:  2017-05-24

9.  Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?

Authors:  Mustafa Kurucay; Christopher Kloth; Sascha Kaufmann; Konstantin Nikolaou; Hans Bösmüller; Marius Horger; Wolfgang M Thaiss
Journal:  Cancer Imaging       Date:  2017-06-28       Impact factor: 3.909

10.  An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice.

Authors:  Bing-Quan Lin; Wen-Biao Zhang; Jing Zhao; Xu-Hui Zhou; Yong-Jiang Li; Jun Deng; Qin Zhao; Gui Fu; Chuan-Miao Xie; Yi-Kai Xu; Guo-Kai Feng
Journal:  J Hepatocell Carcinoma       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.